Overview Drug Interaction Study Between AZD3355 and Nexium Status: Completed Trial end date: 2008-06-01 Target enrollment: Participant gender: Summary The purpose of the study is to evaluate if AZD3355 and Nexium interact with each other or not, i.e. show the same or altered plasma concentration profiles when co-administered compared to administered alone. Phase: Phase 1 Details Lead Sponsor: AstraZenecaTreatments: EsomeprazoleLesogaberan